Supplement Articles

Combination Therapy in Hypertension Management 6/20/2012

The use of combination therapy by a single-dosage form allows patients to achieve their blood pressure goal quickly, improves adverse drug reactions, and is supported by prospective data.

Drug Patent Expirations and the “Patent Cliff” 6/20/2012

Beginning in 2010, the pharmaceutical industry faced one of the biggest waves of drug patent expirations in history, a phenomenon referred to as the “patent cliff.”

Generic Injectable Supply Shortages 6/20/2012

Addressing supply interruptions requires collaboration and guidelines to manage patient care, especially in the midst of highly specialized medication regimens.

Legislative and Regulatory Issues Affecting Generic Drug Reimbursement 6/20/2012

The increased use of generic medications is an important strategy in managing overall pharmaceutical spending, especially by Medicaid and other government-run health programs.

Pharmacy Law: Brand-Name and Generic Drugs Not Equivalent in Malpractice Claims 6/20/2012

Based on last year's Supreme Court ruling, generic manufacturers cannot be held liable for inadequate warning labels.

Trends in Generic Drugs 6/20/2012

More than two-thirds of all prescriptions dispensed in the U.S. are for generic drugs.

Understanding Drug Pricing 6/20/2012

Drug costs are influenced by a variety of factors, and the complexity can be overwhelming for health care professionals and patients alike.